Enovis Corp. (ENOV)

29.68 +0.85 (+2.95%) USD  |  NYSE  |  Jan 09, 16:00
29.75 +0.07 (+0.24%) After-Hours: 20:00
More

Enovis Research and Development Expense (Quarterly): 29.74M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ENOV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Repligen Corp. 14.18M
Twist Bioscience Corp. 17.01M
Perspective Therapeutics, Inc. 19.56M
InfuSystem Holdings, Inc. --
Xtant Medical Holdings, Inc. 0.634M